Wendy Norman, a family doctor and UBC professor who is studying the uptake of Mifegymiso, commented on news that the abortion drug can now be prescribed by a wider range of health professionals.
Norman told the Globe and Mail that the development is a big win for primary care providers.
“Canada, now, is a leader in improving safety and access to abortion for women,” said Norman.
